Rayence Co., Ltd. agreed to acquire additional 11.55% stake in Woorien Co., Ltd. from Murex Search No.1 Fund managed by Murex Partners LLC for KRW 12.5 billion.
May 29, 2024
Share
Rayence Co., Ltd. (KOSDAQ:A228850) agreed to acquire additional 11.55% stake in Woorien Co., Ltd. from Murex Search No.1 Fund managed by Murex Partners LLC for KRW 12.5 billion on May 30, 2024. Under the terms, Rayence will acquire 1 million shares for KRW 12,529,704,837. After the completion of transaction Rayence will have 91.49% stake in Woorien.The transaction is expected to close on May 31, 2024.
Rayence Co., Ltd. is a Korea-based company mainly engaged in the manufacture of medical and veterinary X-ray detector products. Its products include thin film transistor (TFT) detectors and complementary-metal-oxide-semiconductor (CMOS) detectors. The products' brand name consists of 1012WCA, 17SCC/SGC, 1215CF, 1501CF and 0712CF. The Company also manufactures intra oral (I/O) sensors under the brand name of Ez1.0, Ez1.5, and mammography (mammo) machines under the brand 1724CM, 2434CM. The Company distributes its products to domestic and overseas markets.
Rayence Co., Ltd. agreed to acquire additional 11.55% stake in Woorien Co., Ltd. from Murex Search No.1 Fund managed by Murex Partners LLC for KRW 12.5 billion.